Huangqin decoction alleviates lipid metabolism disorders and insulin resistance in nonalcoholic fatty liver disease by triggering Sirt1/NF- κB pathway
CONCLUSION: In summary, our study confirmed that HQD mitigates lipid metabolism disorders and insulin resistance in NAFLD by triggering the Sirt1/NF-κB pathway.PMID:37664157 | PMC:PMC10473922 | DOI:10.3748/wjg.v29.i31.4744
Source: World Journal of Gastroenterology - Category: Gastroenterology Authors: Bao-Fei Yan Lan-Fen Pan Yi-Fang Quan Qian Sha Jing-Zheng Zhang Yi-Feng Zhang Li-Bing Zhou Xi-Long Qian Xiao-Mei Gu Feng-Tao Li Ting Wang Jia Liu Xian Zheng Source Type: research
More News: Chemistry | China Health | Diets | Fatty Liver Disease (FLD) | Gastroenterology | Hepatitis | High Fat | Insulin | Liver | Liver Disease | Non-alcoholic Fatty Liver Diseases (NAFLD) | Nutrition | Study | Urology & Nephrology